Former Pfizer Vice President Mike Yeadon and colleagues who have studied the virus and its related viruses have filed an urgent Motion to halt distribution of the vaccine which was used on faulty information according to the Petitioners.
One major flaw is that the study is based on China’s original input. The Petitioners warn of the health consequences which could be damaging to those injected with the vaccine. :
“The first and major issue is that the novel Coronavirus SARSCoVin the publication named CoV and in February named SARSCoV by an international consortium of virus experts is based on in silico theoretical sequences, supplied by a laboratory in China, because at the time neither control material of infectious live or inactivated SARSCoV nor isolated genomic RNA of the virus was available to the authors. To date no validation has been performed by the authorship based on isolated SARSCoV viruses or full length RNA thereof. According to Corman et al.:
Part of the motion is based on multiple studies that show flaws in the testing of the virus, including a report by an International Consortium of Scientists in Life Sciences ICSLS . “This paper will show numerous serious flaws in the Corman Drosten paper, the significance of which has led to worldwide misdiagnosis of infections attributed to SARSCoV and associated with the disease COVID. We are confronted with stringent lockdowns which have destroyed many people’s lives and livelihoods, limited access to education and these imposed restrictions by governments around the world are a direct attack on people’s basic rights and their personal freedoms, resulting in collateral damage for entire economies on a global scale.” The motion is a very lengthy and technical one that can be found here.
VIDEO posted by Douglas Howey :
Former Pfizer Vice President Mike Yeadon discusses his thoughts as to why the lockdown was a mistake, and why the government strategies to manage the pandemic are only making things worse. The Scientific Advisory Group for Emergencies (SAGE) is a British Government advisory body that advises central government in emergencies.
Dr. Mike Yeadon is an Allergy & Respiratory Therapeutic Area expert, developed out of deep knowledge of biology & therapeutics and is an innovative drug discoverer with 23y in the pharmaceutical industry. He trained as a biochemist and pharmacologist, obtaining his PhD from the University of Surrey (UK) in 1988 on the CNS and peripheralpharmacology of opioids on respiration. Dr Yeadon then worked at the Wellcome Research Labs with Salvador Moncada with a research focus on airway hyper-responsiveness and effects of pollutants including ozone and working in drug discovery of 5-LO, COX, PAF, NO and lung inflammation. With colleagues, he was the first to detect exhaled NO in animals and later to induce NOS in lung via allergic triggers.
Joining Pfizer in 1995, he was responsible for the growth and portfolio delivery of the Allergy & Respiratory pipeline within the company. During his tenure at Pfizer, Dr Yeadon was responsible for target selection and the progress into humans of new molecules, leading teams of up to 200 staff across all disciplines and won an Achievement Award for productivity in 2008.
18 total views, 1 views today